• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy.

作者信息

Glorieux Christophe, Cui Lei, Zeng Peiting, Xia Xiaojun, Huang Peng

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.

Metabolic Innovation Center, Sun Yat-sen University, Guangzhou, Guangdong, 510080, P. R. China.

出版信息

Cancer Commun (Lond). 2021 May;41(5):432-435. doi: 10.1002/cac2.12139. Epub 2021 Mar 2.

DOI:10.1002/cac2.12139
PMID:33650790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8118588/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5af9/8118588/335a924a0424/CAC2-41-432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5af9/8118588/335a924a0424/CAC2-41-432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5af9/8118588/335a924a0424/CAC2-41-432-g001.jpg

相似文献

1
Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy.化疗药物对免疫细胞功能的多种影响及其在免疫化疗中的意义。
Cancer Commun (Lond). 2021 May;41(5):432-435. doi: 10.1002/cac2.12139. Epub 2021 Mar 2.
2
Letter: Cancer immunochemotherapy: the role of immunostimulation.信函：癌症免疫化学疗法：免疫刺激的作用。
Lancet. 1974 May 25;1(7865):1058. doi: 10.1016/s0140-6736(74)90465-6.
3
Immunochemotherapy of cancer.癌症的免疫化学疗法。
Br Med J. 1972 Aug 26;3(5825):486-7.
4
Clinical results with immunochemotherapy in 40 cases of advanced tumour.40例晚期肿瘤患者免疫化疗的临床结果。
Panminerva Med. 1975 May-Jun;17(5-6):208-10.
5
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.顺铂和吉西他滨对 K-ras 驱动型癌症的 PD-1 抗体免疫疗法有相反的影响。
J Adv Res. 2022 Sep;40:109-124. doi: 10.1016/j.jare.2021.12.005. Epub 2021 Dec 21.
6
Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report.在转移性肾细胞癌中，根治性肾切除术联合免疫化疗相对于单纯栓塞术是否具有优势？一项初步报告。
Urol Int. 2004;73(1):54-8. doi: 10.1159/000078805.
7
Immunochemotherapy with Corynebacterium parvum in disseminated cancer.微小棒状杆菌免疫化疗在播散性癌症中的应用
Ann N Y Acad Sci. 1976;277(00):241-51. doi: 10.1111/j.1749-6632.1976.tb41702.x.
8
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.时间依赖性细胞毒性药物与 IL-18 联合选择性用于癌症化疗免疫治疗。
J Transl Med. 2011 May 25;9:77. doi: 10.1186/1479-5876-9-77.
9
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.高免疫球蛋白E综合征患者的弥漫性大B细胞淋巴瘤：基于利妥昔单抗的风险适应性免疫化疗成功治疗
Leuk Res. 2010 Sep;34(9):e232-4. doi: 10.1016/j.leukres.2010.01.024. Epub 2010 Mar 11.
10
Two-Way Cruise Nanosatellite Promotes Metastasis Inhibition by Immunochemotherapy.双向巡航纳米卫星通过免疫化疗促进转移抑制。
Biomacromolecules. 2019 Jul 8;20(7):2873-2887. doi: 10.1021/acs.biomac.9b00788. Epub 2019 Jun 19.

引用本文的文献

1
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy.采用双原子对接策略的可植入式光电化学治疗甲氨蝶呤监测系统
Nat Commun. 2025 Feb 18;16(1):1747. doi: 10.1038/s41467-025-57084-2.
2
Targeting catalase in cancer.靶向肿瘤细胞中的过氧化氢酶。
Redox Biol. 2024 Nov;77:103404. doi: 10.1016/j.redox.2024.103404. Epub 2024 Oct 19.
3
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer.顺铂与卡铂为基础的化疗联合阿替利珠单抗在膀胱癌中的免疫调节作用及改善结局。

本文引用的文献

1
cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.cGAS/STING 轴介导拓扑异构酶 II 抑制剂诱导的肿瘤免疫原性。
J Clin Invest. 2019 Aug 13;129(11):4850-4862. doi: 10.1172/JCI127471.
2
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.癌症的免疫精准医学：基于免疫效应细胞效率的新见解。
Cancer Commun (Lond). 2019 Jun 14;39(1):34. doi: 10.1186/s40880-019-0379-3.
3
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
Cell Rep Med. 2024 Feb 20;5(2):101393. doi: 10.1016/j.xcrm.2024.101393. Epub 2024 Jan 26.
4
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.顺铂和吉西他滨对 K-ras 驱动型癌症的 PD-1 抗体免疫疗法有相反的影响。
J Adv Res. 2022 Sep;40:109-124. doi: 10.1016/j.jare.2021.12.005. Epub 2021 Dec 21.
5
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.铂类药物联合低剂量、长程氟尿嘧啶治疗转移性鼻咽癌的疗效和生存结局。
JAMA Netw Open. 2021 Dec 1;4(12):e2138444. doi: 10.1001/jamanetworkopen.2021.38444.
6
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer.癌基因与氧化还原信号在癌症中对程序性死亡受体1配体（PD-L1）调控的作用
Cancers (Basel). 2021 Sep 2;13(17):4426. doi: 10.3390/cancers13174426.
基于单细胞技术定义的免疫结构用于癌症的预后预测和免疫治疗指导。
Cancer Commun (Lond). 2019 Apr 18;39(1):21. doi: 10.1186/s40880-019-0365-9.
4
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.免疫检查点阻断联合治疗的新兴概念。
Cancer Cell. 2018 Apr 9;33(4):581-598. doi: 10.1016/j.ccell.2018.03.005.
5
Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies.临床相关浓度的抗癌药物：非临床研究指南。
Clin Cancer Res. 2017 Jul 15;23(14):3489-3498. doi: 10.1158/1078-0432.CCR-16-3083. Epub 2017 Mar 31.
6
Chemoimmunotherapy: reengineering tumor immunity.化疗免疫治疗：重塑肿瘤免疫。
Cancer Immunol Immunother. 2013 Feb;62(2):203-16. doi: 10.1007/s00262-012-1388-0. Epub 2013 Feb 7.
7
Classical chemotherapy: mechanisms, toxicities and the therapeutic window.经典化疗：作用机制、毒性及治疗窗
Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S2-4.
8
Mechanisms of action of arsenic trioxide.三氧化二砷的作用机制。
Cancer Res. 2002 Jul 15;62(14):3893-903.
9
Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.卵清蛋白肽/Kb复合物向T细胞的内源性生成及呈递。
J Immunol. 1993 Apr 1;150(7):2724-36.